21.   British Biotech, the leading U.K. biotechnology stock, gained on hopes that its cancer drug trials will bring positive news, analysts said.

22.   But biotechnology stocks, which in many respects are just as speculative and just as profitless, are hanging in there.

23.   But most biotechnology stocks moved higher.

24.   Fund manager Peter Camp attributed much of the good showing to heavy investing in biotechnology stocks.

25.   Genentech president and chief executive G. Kirk Raab said the terms were the best that could be negotiated, given an inhospitable market for biotechnology stocks.

26.   He also advocated above-average holdings of health care companies, especially nursing home operators and health maintenance organizations, and biotechnology stocks.

27.   He was an early and big player in biotechnology stocks.

28.   Hoblyn reckons the stratospheric valuations of some Internet or biotechnology stocks are best avoided, though companies with a proven earnings stream are worth keeping.

29.   In June, Cephalon sparked a rally in biotechnology stocks after it reported positive results from its North American study of Myotrophin.

30.   In June, Cephalon sparked a rally in biotechnology stocks when it reported positive results from its North American study of Myotrophin.